Delivery Order SPE2DX22D0010-SPE2D825FAB71
Award Date
10/2/24
Potential Completion Date
10/3/24
Potential Value
$31K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $26,648.30 firm fixed-price contract is for the supply of 4,565,612,730 capsules of the pharmaceutical product VYVANSE 40MG. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $1,216.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,563,491,536 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. This delivery order does not have a set-aside designation and is being fulfilled by Amerisourcebergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania. The delivery order has a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.61 firm fixed-price contract is for the delivery of 4,567,612,803 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,927.20 firm-fixed-price contract is for the delivery of 4,565,638,359 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The order has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
The federal contract award, valued at $23,974.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This firm fixed price delivery order is for the supply of VYVANSE CAPS 60MG, a specialty pharmaceutical product. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation. The $20,680.47 order is for the delivery of VYVANSE CAPS 40MG pharmaceuticals, with a completion date of March 6, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA as the prime contractor, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $28,592.41 fixed-price contract is for the delivery of VYVANSE CAPS 60MG, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,647,521 units of VYVANSE 30 mg capsules. The $5,470.48 contract, awarded on February 13, 2024, has a completion date of February 14, 2024 and does not use any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will fulfill this order...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,667.38 contract is to provide 4564222091 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to the agency. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
This is a delivery order issued under an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor, AmerisourceBergen Drug Corporation. The order is for the supply of 4,565,231,098 units of the prescription medication VYVANSE 70 MG CAPSULE 100S, with a firm fixed price ceiling value of $1,783.27. The contract has no set-aside designation and the ultimate completion date is July 24, 2024. AmerisourceBergen, a major...